JAK2 (V617F) Mutation by ddPCR, Qualitative with Reflex to JAK2 Exon 12 Mutation Analysis by PCR
Use when a diagnosis of polycythemia vera (PV) is suspected.
Droplet Digital Polymerase Chain Reaction/Polymerase Chain Reaction
DNA Isolation: Sun-Sat
New York DOH Approval Status
Whole blood or bone marrow: Lavender (EDTA), preferred. Also acceptable: Green (sodium heparin).
Whole Blood: Do not freeze. Transport 5 mL whole blood. (Min: 1 mL)
Bone Marrow: Do not freeze. Transport 3 mL bone marrow. (Min: 1 mL)
Plasma, serum, FFPE tissue blocks/slides, or fresh or frozen tissue, DNA extracted by a non-CLIA certified lab. Specimens collected in anticoagulants other than EDTA or sodium heparin. Clotted or grossly hemolyzed specimens.
Refrigerated: 7 days; Frozen: Unacceptable
Refer to report.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
If JAK2 QUAL is reported as "Not Detected" then JAK2 Exon 12 Mutation Analysis will be added. Additional charges apply.
81270; if reflexed, add 81279
|Component Test Code*||Component Chart Name||LOINC|
|3004047||JAK2 QUAL, Source||31208-2|
|3004048||JAK2 QUAL Mutation by PCR||43399-5|
- JAK2 Exon 12
- Janus Kinase 2 Gene
- Janus Kinase 2 Gene Sequencing
- MPN JAK2 testing